Tesaro, Inc. (Waltham, Massachusetts)

230 articles with Tesaro, Inc. (Waltham, Massachusetts)

• Tesaro, Inc. Announces First-Quarter 2014 Operating Results

  5/1/2014

• Tesaro, Inc. To Announce First Quarter 2014 Financial Results On April 30, 2014

  4/17/2014

• Tesaro, Inc. Announces Data Presentations At 2014 American Association for Cancer Research Annual Meeting

  4/2/2014

• Myriad Genetics, Inc. Announces HRD Companion Diagnostic Collaboration With Tesaro, Inc.

  3/24/2014

• Tesaro, Inc., AnaptysBio, Inc. Strike Immuno-Oncology Pact Worth $125 Million

  3/13/2014

• Tesaro, Inc. To Present At The Barclays Global Healthcare Conference

  3/6/2014

• Tesaro, Inc. Announces Fourth-Quarter And Full-Year 2013 Operating Results

  2/20/2014

• Tesaro, Inc. To Announce Fourth Quarter 2013 Financial Results On February 19, 2014

  2/7/2014

• Tesaro, Inc. To Present At Two Upcoming Investment Conferences

  2/6/2014

• Tesaro, Inc. Announces Pricing Of Public Offering Of Common Stock

  1/30/2014

• Tesaro, Inc. Announces Proposed Public Offering Of Common Stock

  1/29/2014

• Tesaro, Inc. To Present At The 32nd Annual J.P. Morgan Healthcare Conference

  1/7/2014

• Tesaro, Inc. To Present At The 2013 Deutsche Bank Biofest Conference

  11/26/2013

• Tesaro, Inc. to Announce Third Quarter 2013 Financial Results on November 7, 2013

  10/24/2013

• Tesaro, Inc. Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 2013

  9/30/2013

• Tesaro, Inc. Announces Initiation of Rolapitant IV Clinical Program

  9/30/2013

• Tesaro, Inc. to Participate in Several Upcoming Investor Conferences

  8/30/2013

• Tesaro, Inc. Announces Second-Quarter 2013 Operating Results

  7/26/2013

• Tesaro, Inc. Initiates Phase 3 Trial of Niraparib for Treatment of Patients With Ovarian Cancer

  7/23/2013

• Tesaro, Inc. to Announce Second Quarter 2013 Financial Results on July 25, 2013

  7/18/2013